Robotic-assisted endoscopic submucosal dissection: a scoping review of preclinical and early clinical evidence - Scorecard - MDSpire

Robotic-assisted endoscopic submucosal dissection: a scoping review of preclinical and early clinical evidence

  • By

  • Said Alyacoubi

  • Kunal Rajput

  • Mark Runciman

  • Ara Darzi

  • Christopher J. Peters

  • George Mylonas

  • July 1, 2026

  • 0 min

Share

Clinical Scorecard: A Comprehensive Review of Preclinical and Initial Clinical Findings on Robotic-Assisted Endoscopic Submucosal Dissection

At a Glance

CategoryDetail
ConditionEndoscopic Submucosal Dissection (ESD)
Key MechanismsRobotic assistance provides triangulation, active countertraction, enhanced visualisation, and improved ergonomics.
Target PopulationPatients with precancerous lesions and early-stage cancers of the gastrointestinal tract.
Care SettingClinical and preclinical settings evaluating robotic endoscopic systems.

Key Highlights

  • ESD offers superior curative resection rates compared to EMR.
  • Robotic-assisted ESD (R-ESD) may reduce procedural demands and accelerate skill acquisition.
  • Traction-assisted ESD leads to shorter procedure times and reduced technical difficulty.

Guideline-Based Recommendations

Diagnosis

  • Evaluate the feasibility and safety of robotic-assisted ESD in early clinical evidence.

Management

  • Utilize robotic systems to enhance ESD procedures.

Monitoring & Follow-up

  • Assess outcomes such as resected specimen area and perforation rates.

Risks

  • Higher complication risk associated with ESD compared to EMR.

Patient & Prescribing Data

Patients undergoing ESD for gastrointestinal lesions.

Robotic systems may facilitate wider adoption of ESD across varying levels of endoscopic expertise.

Clinical Best Practices

  • Implement traction methods to improve dissection efficiency.
  • Adopt robotic platforms to enhance procedural ergonomics.

Related Resources & Content

Original Source(s)

Related Content